I’ve been waiting for one of those nine bare-breasted sisters to land by my side and inspire a sonnet...
Opioids, suicide, and Alzheimer disease all play a large role in the life expectancy drop reported by the CDC.
Here is a selection of eight research developments that may impact psychiatric clinical practice in the coming years.
On behalf of the editorial staff, we are very pleased to welcome Dr John J. Miller as the new Editor in Chief of Psychiatric Times and Dr Scott L. Zeller who recently joined our Editorial Board.
Autism was first described by child specialists, and even today most autism-specific services are focused only on children. This CME provides a comprehensive overview of autism in adults.
Are mood stabilizers causing strokes? Can we treat bipolar II without medication? The past year brought answers to these questions and more.
It turns out that sleep deprivation has an effect not only on the traditional concept of “beauty,” but also on whether a person is perceived as being socially desirable.
When engaging in professional discourse on controversial topics, how can psychiatrists respect the therapeutic boundary with patients when their own fears are heightened?
Many trauma survivors do not enjoy their life due to their daily struggles with memories in the aftermath. Wounded healers are no exception. More in this Portrait of a Psychiatrist.
We cannot protect our patients without protecting our planet. This means a personal and professional commitment to green our activities by considering the carbon effects of how we do our work.
Recent studies and meta-analyses discussed here address mental health hospitalization, optimal treatment, and long-term outcome for children and adolescents with anxiety disorders.
"He'll just have to hit bottom." That bit of outdated advice can be terrifying. How do clinicians trying to help the person with an addiction who refuses to set foot in our office render assistance?
Peter F. Buckley, MD introduces part 1 of our Special Report on schizophrenia.
Two compelling case reports provide additional evidence for potential mechanistic associations between the immune system and schizophrenia.
Antipsychotic drugs are the cornerstone in the management of psychotic disorders, but most patients fail to have a “good” response in short-term trials. Alternative strategies are presented here.